Company registration number 3970363 (England and Wales)
SPHERE SCIENCE LIMITED
Unaudited financial statements
For the year ended 31 July 2025
Pages for filing with registrar
SPHERE SCIENCE LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Statement of changes in equity
3
Notes to the financial statements
4 - 7
SPHERE SCIENCE LIMITED
BALANCE SHEET
As at 31 July 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
451
595
Current assets
Debtors
5
42,083
5,688
Cash at bank and in hand
36,399
74,200
78,482
79,888
Creditors: amounts falling due within one year
6
(11,707)
(8,027)
Net current assets
66,775
71,861
Total assets less current liabilities
67,226
72,456
Provisions for liabilities
(75)
(113)
Net assets
67,151
72,343
Capital and reserves
Called up share capital
7
2
3
Profit and loss reserves
67,149
72,340
Total equity
67,151
72,343

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

SPHERE SCIENCE LIMITED
BALANCE SHEET (CONTINUED)
As at 31 July 2025
2025
2024
Notes
£
£
£
£
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 8 December 2025 and are signed on its behalf by:
S Sisson
Director
Company Registration No. 3970363
SPHERE SCIENCE LIMITED
STATEMENT OF CHANGES IN EQUITY
For the year ended 31 July 2025
- 3 -
Share capital
Profit and loss reserves
Total
£
£
£
Balance at 1 August 2023
3
87,012
87,015
Year ended 31 July 2024:
Loss and total comprehensive income
-
(14,672)
(14,672)
Balance at 31 July 2024
3
72,340
72,343
Year ended 31 July 2025:
Profit and total comprehensive income
-
19,933
19,933
Own shares acquired
(1)
(25,124)
(25,124)
Balance at 31 July 2025
2
67,149
67,151
SPHERE SCIENCE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
For the year ended 31 July 2025
- 4 -
1
Accounting policies
Company information

Sphere Science Limited is a private company limited by shares incorporated in England and Wales. The registered office is 27 Fantail Lane, Tring, Hertfordshire, HP23 4EN.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

At the time of approving the financial statements, the directors have undertaken an assessment of the adequacy of the resources available to the company and have taken in to account the impact of the coronavirus on the company as well as the expected support to businesses available from the government measures in place through the period of disruption caused by coronavirus. The directors have a reasonable expectation the company has adequate resources to continue in operational existence for the foreseeable future and accordingly continue to adopt the going concern basis of accounting in preparing the financial statements.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

 

Revenue from the provision of educational workshop is recognised when the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings
33% reducing balance
Computers
33% reducing balance
1.4
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

1.5
Cash and cash equivalents

Cash at bank and in hand are basic financial assets and include cash in hand, deposits held at call with banks and other short-term liquid investments with original maturities of three months or less.

SPHERE SCIENCE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
For the year ended 31 July 2025
1
Accounting policies
(Continued)
- 5 -
1.6
Financial instruments
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method.

Basic financial liabilities

Basic financial liabilities, including creditors, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Changes in the fair value of derivatives that are designated and qualify as fair value hedges are recognised in profit or loss immediately, together with any changes in the fair value of the hedged asset or liability that are attributable to the hedged risk.

1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

SPHERE SCIENCE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
For the year ended 31 July 2025
- 6 -
3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
2
3
4
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 August 2024
11,980
Disposals
(11,176)
At 31 July 2025
804
Depreciation and impairment
At 1 August 2024
11,385
Depreciation charged in the year
144
Eliminated in respect of disposals
(11,176)
At 31 July 2025
353
Carrying amount
At 31 July 2025
451
At 31 July 2024
595
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
18,720
1,200
Other debtors
23,363
4,488
42,083
5,688
SPHERE SCIENCE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
For the year ended 31 July 2025
- 7 -
6
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
457
834
Taxation and social security
1,813
4,026
Other creditors
9,437
3,167
11,707
8,027
7
Called up share capital
2025
2024
£
£
Ordinary share capital
Issued and fully paid
8 (2024: 12) Ordinary of 25p each
2
3
8
Directors' transactions

Dividends totalling £0 (2024 - £0) were paid in the year in respect of shares held by the company's directors.

At the year end £483 (2024: £483) was payable to the directors of the company.

2025-07-312024-08-01falsefalsefalse08 December 2025CCH SoftwareCCH Accounts Production 2025.300No description of principal activityS  LangfordM  Post39703632024-08-012025-07-3139703632025-07-3139703632024-07-313970363core:OtherPropertyPlantEquipment2025-07-313970363core:OtherPropertyPlantEquipment2024-07-313970363core:CurrentFinancialInstrumentscore:WithinOneYear2025-07-313970363core:CurrentFinancialInstrumentscore:WithinOneYear2024-07-313970363core:CurrentFinancialInstruments2025-07-313970363core:CurrentFinancialInstruments2024-07-313970363core:ShareCapital2025-07-313970363core:ShareCapital2024-07-313970363core:RetainedEarningsAccumulatedLosses2025-07-313970363core:RetainedEarningsAccumulatedLosses2024-07-313970363core:ShareCapital2023-07-313970363core:RetainedEarningsAccumulatedLosses2023-07-3139703632023-07-313970363core:ShareCapitalOrdinaryShareClass12025-07-313970363core:ShareCapitalOrdinaryShareClass12024-07-313970363bus:Director12024-08-012025-07-313970363core:RetainedEarningsAccumulatedLosses2023-08-012024-07-3139703632023-08-012024-07-313970363core:RetainedEarningsAccumulatedLosses2024-08-012025-07-313970363core:FurnitureFittings2024-08-012025-07-313970363core:ComputerEquipment2024-08-012025-07-313970363core:OtherPropertyPlantEquipment2024-07-313970363core:OtherPropertyPlantEquipment2024-08-012025-07-313970363bus:PrivateLimitedCompanyLtd2024-08-012025-07-313970363bus:SmallCompaniesRegimeForAccounts2024-08-012025-07-313970363bus:FRS1022024-08-012025-07-313970363bus:AuditExemptWithAccountantsReport2024-08-012025-07-313970363bus:Director22024-08-012025-07-313970363bus:FullAccounts2024-08-012025-07-31xbrli:purexbrli:sharesiso4217:GBP